BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

RAYNER — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Termination

RAYNER

via WILLIAMS AND JENSEN, PLLC

1st Quarter (Jan 1 - Mar 31) · 2026Posted Apr 20, 2026Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: RAYNER
Description: Manufacturer of ophthalmic medical products.
Location: United Kingdom

Registrant

Firm: WILLIAMS AND JENSEN, PLLC
Description: Lobbying Law Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Medicare coverage issue for non-opioid product. Reauthorization of NOPAIN Act.
LobbyistsSUSAN HIRSCHMANN · LAURA M SIMMONS · JEANNE HAGGERTY
Covered position (LAURA M SIMMONS): Advisor, Office of Legislative Affairs, Dept of Homeland Security
Covered position (JEANNE HAGGERTY): Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.